COR
Cencora, Inc.
September 30, 2026 · market open
- Rarity
- 1.19
- Peak move
- −3.42%
- Float cap
- $59.4B
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. It distributes brand-name, specialty, generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment to hospitals, health systems, pharmacies, clinics, physician practices, veterinarians, and other providers. It also offers data analytics, consulting, logistics, inventory management, pharmacy automation, and packaging services to healthcare providers and pharmaceutical manufacturers.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
2 events · 0 from SEC or newswire · 1 timed with the move- Timed with the move
analyst_ratingLeerink analysts published a note on Cardinal Health after meeting the drug distributor's CFO and investor relations team, saying specialty offerings, MSO value, at-home growth and capital redeployment remain far from "late innings."
board_changeCencora's board elected Robert E. Sanchez, Executive Chair of Ryder System and its former Chair and CEO until March 2026, as a new independent director effective October 1, 2026, expanding the board from 10 to 11 seats.